Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial. (linkinghub.elsevier.com)

Authors: Welch M … Chen Y Journal: The Lancet Published: 2026-06-08 DOI: https://doi.org/10.1016/S0140-6736(26)00800-7